<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 24, 2000
(Date of Report - earliest event reported)
SPIROS DEVELOPMENT CORPORATION II, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 000-23501 33-0774288
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
7475 LUSK BOULEVARD, SAN DIEGO, CALIFORNIA 92121
(Address of principal executive offices) (Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE IS (858) 457-2553
<PAGE>
Item 5. Other Events.
On July 24, 2000, Dura Pharmaceuticals, Inc. ("Dura") announced
implementation of a refocused growth strategy to enhance stockholder value.
Dura will capitalize upon its strengths in sales and marketing to increase
pharmaceutical product revenues and substantially reduce and focus its
research and development spending. As part of the strategy, Dura will, upon
the successful completion of the proposed acquisition of Spiros Development
Corporation II, Inc. ("SDCII"), discontinue the development of all motorized
Spiros(R) cassette programs, including Beclomethasone Spiros(TM) and
Budesonide Spiros(TM). Upon completion of the proposed acquisition, David S.
Kabakoff, Ph.D., President and Chief Executive Officer of SDCII and President
of Dura Technologies, plans to leave Dura to pursue other interests. Lloyd E.
Flanders, Ph.D., currently Senior Vice President, Program Management and
Research and Development Planning, will assume the new role of Senior Vice
President, Technology Operations.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
C. Exhibits
*99.1 Press Release of Dura Pharmaceuticals, Inc. dated July 24, 2000.
*Incorporated by reference to Exhibit 99.1 of Dura Pharmaceuticals,
Inc.'s Form 8-K filed July 25, 2000.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report on Form 8-K to be signed on its behalf by
the undersigned hereunto duly authorized.
SPIROS DEVELOPMENT CORPORATION II, INC.
Date: July 25, 2000 /s/ Erle T. Mast
--------------------------------------
Vice President, and Chief Financial
Officer
3
